课题基金 / 基金详情

CALCIFICATION IN THE CARDIOVASCULAR SYSTEM

CALCIFICATION IN THE CARDIOVASCULAR SYSTEM
心血管系统钙化
批准号:
3341057
负责人:
Naomi Eidelman
金额:
$20.18万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 1994-06-30

项目摘要

项目成果

Naomi Eidelman的其他基金

相似基金

相关文献

中文摘要
翻译
总体目标是发展足够的动力学信息,
英文摘要
The overall objective is to develop sufficient information on the kinetic, thermodynamic, and structural properties of cardiovascular calcific deposits to make possible prevention and cure of this aspect of the pathology. There is strong evidence that the calcification occurs by way of acidic calcium phosphate (containing HPO4) precursors, the formation rates of which can be reduced by physiologically acceptable inhibitors. Specific aims: I. Calcification modifiers, including Zn2+, Mg2+, Sr2+, and P2O74- ions, will be evaluated for their comparative abilities to alter rates of calcification. II. The applicability of the calcification mechanism will be tested by following the progression of bovine pericardium implant calcification in rats using a 32P-pyrolysis technique and Ca/P ratio measurements of the deposits. III. Deposits from different sites of the cardiovascular system will be analyzed to determine whether there are similarities that would indicate indirectly a common mechanism that controls their formation. IV. A comparison will be made of the products obtained by the direct versus the precursor calcification mechanism; one aspect of this is to determine conditions that lead to the formation of stoichiometric hydroxyapatite. V. The compositions and structures of the precursors of bioapatites found in cardiovascular deposits will be determined with the use of chemical analysis, IR, X-ray powder diffraction, and single-crystal analysis. VI. An alternative mechanism for the incorporation of carbonate found in cardiovascular deposits will be investigated. A hypothesis to be tested is that one of the precursors can incorporate carbonate into its structure to form a salt that will hydrolyze to carbonate apatite under physiological conditions. Elemental analyses, XRD, Raman and IR will be used to characterize the compounds. VII. A determination of the solubility of whitlockite, which is Ca18Mg2H2(PO4)14, occasionally found in other biological tissues, will help determine whether it could be a component of calcified cardiovascular deposits, which contain Mg ions. VIII. Mechanisms that cause intrinsic (subsurface) calcification of tissue-derived implants will be investigated. The results will characterize the permselective membrane properties of implant tissues and determine the diffusion features of physiological ions into the tissues. Contemporary experimental designs and statistical methods for analyzing data will be used.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nicolet Continumm XL FTIR Microscope System
CALCIFICATION IN THE CARDIOVASCULAR SYSTEM
CALCIFICATION IN THE CARDIOVASCULAR SYSTEM
CALCIFICATION IN THE CARDIOVASCULAR SYSTEM
海外基金